All News #Library
Rare Diseases
Tanabe Pharma America Completes RADICAVA Transfer To Shionogi
01 Apr 2026 //
PR NEWSWIRE
Shionogi Enrolls First Patients In Global Phase 2 Trial
19 Mar 2026 //
PHARMIWEB
Shionogi & Guardian Launch 1st Drug Study for Jordan’s Syndrome
04 Feb 2025 //
BUSINESSWIRE

Market Place
Sourcing Support